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Available online 23 October 2015Increased hyperphosphorylated tau and the formation of intracellular neuroﬁbrillary tangles are associated with
the loss of neurons and cognitive decline in Alzheimer's disease, and related neurodegenerative conditions. We
applied two diffusion models, diffusion tensor imaging (DTI) and neurite orientation dispersion and density im-
aging (NODDI), to in vivo diffusion magnetic resonance images (dMRI) of a mouse model of human tauopathy
(rTg4510) at 8.5 months of age. In greymatter regionswith the highest degree of tau burden, microstructural in-
dices provided by both NODDI and DTI discriminated the rTg4510 (TG) animals from wild type (WT) controls;
however only the neurite density index (NDI) (the volume fraction that comprises axons or dendrites) from
the NODDI model correlated with the histological measurements of the levels of hyperphosphorylated tau pro-
tein. Reductions in diffusion directionality were observed when implementing both models in the white matter
region of the corpus callosum, with lower fractional anisotropy (DTI) and higher orientation dispersion (NODDI)
observed in the TG animals. In comparison to DTI, histological measures of tau pathology were more closely
correlated with NODDI parameters in this region. This in vivo dMRI study demonstrates that NODDI identiﬁes
potential tissue sources contributing to DTI indices and NODDI may provide greater speciﬁcity to pathology in
Alzheimer's disease.
© 2015 Elsevier Inc. All rights reserved.Introduction
The progression of soluble tau protein to neuroﬁbrillary tangles
(NFTs) is at the centre of many human neurodegenerative diseases, in-
cluding Alzheimer's disease (AD) (Spillantini and Goedert, 2013). A
known function of tau protein is to stabilise axonal microtubules. How-
ever, in AD these proteins disassociate resulting in a breakdown of the
microtubules and aggregation of insoluble hyperphosphorylated tau
ﬁlaments, impairing neural pathways (Ballatore et al., 2007). Tau
aggregates form within discrete neurites in select nerve cells and
propagate, effecting downstream synaptically connected brain regions
(de Calignon et al., 2012; Pooler et al., 2013; Ahmed et al., 2014).Monitoring the progression of tau and its effect on neuronal reorganiza-
tion due to tau-induced neurodegeneration in vivo is a key requirement
in understanding the progression of AD and determining the efﬁcacy of
current therapeutic attempts to target tauopathies (de Calignon et al.,
2012; Ahmed et al., 2014).
To study these effects, we used an animal model of tau pathology:
the TG mouse model which overexpresses a mutant form of human
tau (P301L) resulting in tau accumulation in the form of NFTs largely
restricted to the hippocampus, cortex, olfactory bulb, and striatum
(Santacruz et al., 2005). These NFTs are an intracellular hallmark of AD
and are believed to lead to neuronal dysfunction, neurotoxicity and
brain atrophy resulting in neurological deﬁcits and neuronal cell death
(Santacruz et al., 2005). Current understanding of tau propagation in
synaptically connected brain regions is primarily obtained from invasive
tissue measurements using immunohistological methods (Liu et al.,
2012; Hardy and Revesz, 2012), which are restricted to single time
point analyses and do not allow in vivo dynamic assessment of tissue re-
modelling due to pathology.
740 N. Colgan et al. / NeuroImage 125 (2016) 739–744Diffusion magnetic resonance imaging (dMRI) is sensitive to the
diffusion process of MR visible molecules. In biological tissue, dMRI
techniques provide indices associated with the dispersion pattern of
watermolecules, which reﬂect the integrity of the tissuemicrostructure
in vivo (Basser and Pierpaoli, 1996). Most previous studies of AD related
pathologies have applied a tensor model referred to as diffusion tensor
imaging (DTI) to investigate changes in neuronal cytoarchitecture
(Assaf and Pasternak, 2008; Horsﬁeld and Jones, 2002) and age related
changes in the TG mouse model (Sahara et al., 2014; Wells et al.,
2015). However, the common diffusion tensormodel is based on the as-
sumption of a simple underlying Gaussian diffusion process (Alexander
et al., 2002). In contrast, the neurite orientation dispersion and density
imaging (NODDI) technique uses a non-Gaussian biophysical model,
providing higher sensitivity to the non-monoexponential diffusion in
the brain parenchymal environment (Alexander et al., 2002; Syková
and Nicholson, 2008). In tauopathies, where the densely packed micro-
tubules in neurite structures become destabilised and tau protein
misfolds to form NFTs, diffusion MRI techniques that use biophysical
models of tissue (Vestergaard-Poulsen et al., 2011; Jespersen et al.,
2012; Hansen et al., 2011;Wang et al., 2013) may have higher speciﬁc-
ity to changes in tissue cytoarchitecture and the pathological processes
of tau accumulation.
NODDI is a recent microstructure imaging technique based on diffu-
sion MRI but using diffusion gradients of different strengths to provide
more speciﬁc indices of tissue microstructure than DTI (Zhang et al.,
2012). NODDI relies on a biophysical model that separates the diffusion
ofwater in brain tissue into three types ofmicrostructural environment:
intra-neurite, extra-neurite, and cerebrospinal ﬂuid (CSF) compart-
ments (Zhang et al., 2012). To achieve this, NODDI applies a two level
approach by separating the volume fraction of Gaussian isotropic
diffusion (IsoVF), representing the freely diffusing water (i.e. CSF),
from the neural tissue (Zhang et al., 2012). The remaining signal is
sub-compartmentalised into components from intra and extra-neurite
water, which are non-exchanging. This separation yields important
markers: the neurite density index (NDI) (the fraction of tissue that
comprises axons or dendrites) and the interdependent extra-neurite
volume fraction (the fraction of tissue other than neurites) (Zhang
et al., 2012). The dispersion of the neurite structures is further
characterised by the orientation dispersion index (ODI) which reﬂects
the spatial conﬁguration of the neurite structures, with large values of
ODI corresponding to highly dispersed neurites (e.g. grey matter) and
small values of ODI to highly aligned axons (e.g. white matter tracts)
(Zhang et al., 2012).
In this study, we sought to determine the effectiveness of NODDI as
an in vivo imagingmarker to detect tau pathology and demonstrate the
improved speciﬁcity of the technique over standard DTI measures for
detecting AD-like pathology. We report the correlations of both models
with immunohistological stains for ﬁlamentous tau and evaluate each
technique's speciﬁcity to tau pathology.
Methods
Generation of homozygous rTg4510 transgenic mice has been re-
ported previously (Ramsden et al., 2005). Mice were licensed from the
Mayo Clinic (Jacksonville Florida, USA) and bred for Eli Lilly by Taconic
(Germantown, USA). Micewere imported to the UK for imaging studies
at the Centre for Advanced Biomedical Imaging (CABI), London. All
studies were carried out in accordance with the United Kingdom's Ani-
mals (Scientiﬁc Procedures) Act of 1986.
Five TG and ﬁveWT female litter matched mice (8.5 months of age)
were imaged. The animals were placed in an induction chamber and
anesthetised with inhaled isoﬂurane (2% isoﬂurane at 1 l/min O2)
until pedal withdrawal reﬂex was lost. They were then transferred to
anMRI compatible head holder tominimisemotion artefacts andmain-
tained at 1.5% isoﬂurane at 1 l/min O2 for the duration of scanning. Core
temperature wasmaintained at 37 °C using awarm air blower feedbacksystem and rectal probe (SA instruments). Physiological monitoring of
temperature and respiration was recorded throughout the scan (SA
instruments).
The scans were performed on a 9.4T Agilent scanner with Vnmrj 3.1
front end software using the Agilent 205/120HD gradient set. RF trans-
missionwas performedwith a 72mm inner diameter volume coil and a
4-channel receiver coil (Rapid Biomedical).
Diffusion-weighted images were acquired using a 4-shot spin echo-
planar imaging (EPI) sequence over sixteen slices. The olfactory bulbs
were used as an anatomical landmark to maintain consistency in slice
positioning between animals and the slices covered the cortex and
subcortical structures up to the cerebellum. Imaging parameters were:
FoV 20 × 20 mm2, resolution 200 × 200 μm, 16 × 500 μm axial slices,
TR = 2 s, TE = 24 ms. To enable the NODDI analysis, the diffusion
MRI protocol consisted of two shells, which were:
1. Shell one: 30 directions, four b = 0 and b = 2000 s/mm2 with pa-
rameters: G = 0.349 T/m, Δ= 9.3 ms, δ= 5.5 ms, TR = 2000 ms.
2. Shell two: 20 directions, three b = 0 and b = 1000 s/mm2 with pa-
rameters: G = 0.250 T/m, Δ= 9.3 ms, δ= 5.5 ms, TR = 2000 ms.
Imageswere corrected formotion using 2D rigid body registration to
a reference volume (ﬁrst b = 0 image) using DTI-TK (Zhang et al.,
2006). Brain masks were created manually with Matlab (Mathworks
version 7.1) and the NODDI microstructure parameter maps were esti-
mated from motion-corrected images using the NODDI toolbox
(Zhang et al., 2012). The DTI metrics of fractional anisotropy (FA) and
mean diffusivity (MD) were generated from the Camino toolbox
(Cook et al., 2006) using weighted linear least-squares.
Regions of interests (ROIs) were drawn on the three coronal FA
maps (Supplementary Fig. 1) which align with anatomical location of
histology (−2mm frombregma). The four ROIswere the cortex, corpus
callosum, hippocampus and thalamus (Fig. 2B); all were manually
drawn by the lead author (NC)whowas blinded for genotype. These in-
cluded: Cortex: retrosplenial agranular, retrosplenial granular, motor
and somatosensory cortices; Hippocampus: CA1, CA2, CA3 and dentate
gyrus; Corpus Callosum: dorsal fornix, corpus callosum, alveus and
cingulum; Thalamus: ventral posteromedial nucleus, posterior com-
plex, parafascicular nucleus, lateral posterior nucleus, lateral medial
habenula, lateral geniculate complex and intermedial dorsal nucleus.
Mean ROI values for FA, MD, ODI, NDI and IsoVF were exported in
spreadsheet form for statistical analysis.
The intraneurite compartment in healthy grey matter is highly dis-
persed due to sprawling dendritic processes (Zhang et al., 2012). In
this TG mouse model there is a large dendritic degeneration in cortical
regions of the grey matter (Santacruz et al., 2005). This would cause a
reduction in dispersion and would be reﬂected by reduced ODI. The re-
duction in dendritic volume would also cause a reduction in NDI (the
volume fraction that comprises the intraneurite compartment). Healthy
whitemattermainly contains highly orientated axon bundles. In tau pa-
thology, the microtubules of the axon bundles dissociate (Santacruz
et al., 2005) which should lead to higher diffusion tortuosity in
intraneurite compartment. An increase in diffusion tortuosity would
be reﬂected by an increase in dispersion (higher ODI) and as the
white matter region thins, a reduction in the neurite density volume
(lower NDI). Any increase or decrease in free isotropic diffusion respec-
tively reﬂects a higher or lower value measured through the tissue vol-
ume fraction (Zhang et al., 2012).
Directly after in vivo imaging the animals are removed from theMRI
scanner and terminally anaesthetised with Euthanal (0.1 mL) adminis-
tered via intraperitoneal injection. The thoracic cavities were opened
and the animals perfused through the left ventricle of the heart with
15–20 mL of saline (0.9%) followed by 50 mL of buffered formal saline
at a ﬂow rate of 3 mL per minute. Following perfusion, the animal was
decapitated, deﬂeshed and the lower jaw removed. All brains were
stored in-skull in buffered formal saline at 4 °C before being dispatched
for histology.
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cessor (GMI Inc, MN USA). After processing, sections were embedded
in parafﬁn wax to allow coronal brain sections to be cut. Serial sections
(6–8 μm) were taken using HM 200 and HM 355 (Thermo Scientiﬁc
Microm, Germany) rotary microtomes.
Immunohistochemistry (IHC) was performed using a primary anti-
body for tau phosphorylated at serine 409 (PG-5; 1:500 from Peter Da-
vies, Albert Einstein College of Medicine, NY, USA). Secondary antibody
was applied and slides were then incubated with avidin biotin complex
(ABC) reagent for 5 min (M.O.M. kit PK-2200, Elite ABC rabbit kit PK-
6101, or Elite RTU ABC PK-7100 Vector Labs). After rinsing, slides
were treated with the chromogen 3, 3′-diaminobenzidine (DAB; Vector
Laboratories, SK-4100) to allow visualisation. The slides were then
cover slipped, dried and digitised using an Aperio Scanscope XT (Aperio
Technologies Inc., CA, USA).
Imageswere viewed and analysedwith Aperio ImageScope software
(version 10.2.2319). In this study, two sections that align with the diffu-
sion slices for each mouse were analysed. For each section stained, re-
gions of speciﬁc interest (in this case the cortex, corpus callosum,
hippocampus and thalamus) were delineated. The density of PG-5 im-
munoreactivity was quantiﬁed within these regions of interest using
Aperio ImageScope and exported into spreadsheets for statistical com-
parison with diffusion measurements.
The t-test of group differences betweenWT and TG and Pearson cor-
relations of diffusion metrics with PG-5 immunoreactivity were carried
out using Graphpad Prism (version 5) (Motulsky et al., 1994). Adjust-
ment for multiple comparisons was performed for each model using
false discovery rate (FDR) correction and the level of signiﬁcance was
set at 0.05.
Results
Representative maps of fractional anisotropy (FA), mean diffusivity
(MD), orientation dispersion (ODI), neurite density (NDI), and isotropic
diffusion (IsoVF) for WT and TG mice are presented in Fig. 1. The FA
and ODI maps show the highly anisotropic nature of the corpus
callosumwhitematter. The IsoVFmap clearly delineates CSF and the as-
sociated ventricular enlargement in the TG.
The output of the ROI analysis of the four regions selected: three grey
matter regions (cortex, hippocampus and thalamus) and one white
(corpus callosum) (Fig. 2B), were compared with the percentage tau
burden measured through immunohistology in the same four regions.Fig. 1. Representative coronal FA, MD (× 10− 9 m2/s), OThe cortex and the hippocampus, as expected, presented with the
highest degree of tau burden and the thalamus had the lowest tau bur-
den (Fig. 2A).
Cortex
In the cortex (regionwith the highest tau burden, Fig. 2A), all NODDI
parameters distinguished the TG group from the WT group. The TG
group had lower ODI (Tratio = 3.8, df = 8, p b 0.01), higher NDI
(Tratio = 4.7, df = 8, p b 0.001) and higher IsoVF (Tratio = 3.6, df =
8; p b 0.01) in the TG group (Fig. 3A). Therewas also a signiﬁcant higher
MD (Tratio = 3.9, df = 8, p b 0.01) (Fig. 3A) in the TG group. However,
only neurite density (NDI) correlated signiﬁcantly with the degree of
tau burden (p b 0.002) (Fig. 4A).
Hippocampus
In the hippocampus (region with the second highest tau burden,
Fig. 2A), there was a signiﬁcantly higher FA (Tratio = 4.7; df = 8;
p b 0.01) and MD (Tratio = 6.6; df = 8; p b 0.01), as well as lower
ODI (Tratio = 12.6; df = 8; p b 0.0001) and NDI (Tratio = 5.9; df =
8; p b 0.01) in the TG group, with no separation between groups in
the IsoVF (Fig. 3B). As in the cortex, NDI was the only parameter
which correlated with the percentage of tau burden (p b 0.01) (Fig. 4B).
Thalamus
In the thalamus (regionwith the lowest tau burden, Fig. 2A), FA,MD,
ODI and NDI could not discriminate betweenWT and TG groups. How-
ever there was a signiﬁcantly lower isotropic diffusion volume fraction
(IsoVF) in the TG mice compared with WT animals (Tratio = 2.9;
df = 8; p b 0.05) (Fig. 3D).
Corpus callosum
In the corpus callosum ROI, there was greater tau staining observed
than in the thalamus but less than in the hippocampus and the cortex
(Fig. 2A). In the TG group, there was lower anisotropy (FA, Tratio =
3.9; df = 8; p b 0.05) and higher dispersion (ODI, Tratio = 9.6; df =
8; p b 0.01) and diffusivity (MD, Tratio = 5.1; df = 8; p b 0.01), with
a lower neurite density (NDI, Tratio = 3.6; df = 8; p b 0.05) in the TG
group (Fig. 3C). In this white matter region both FA (R2 = 0.79 andDI, NDI and IsoVF maps at−2 mm from bregma.
Fig. 2. Percentage tau burdenmeasured for each animal based on distinct anatomical regions (A) and representative brainmaps of tau immunohistology and regions of interest in TG4510
(B) and wildtype (C) animals.
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den (Fig. 4C & D), however ODI demonstrated a far stronger correlation
(R2 = 0.96 and p = 0.003).
Discussion
In this work, we have shown that NODDI indices correlatedwith his-
tological measurements of tau pathology in grey matter regions in a
mouse model of human tauopathy whereas traditional DTI indices of
MD and FA do not.
The signiﬁcantly lower FA in the white matter tract of the corpus
callosum (CC) is in good agreement with previous studies of the TG an-
imals at 8 months (Sahara et al., 2014;Wells et al., 2015). Lower FA and
higherMD in the CC have been reported in AD patients when compared
with healthy volunteers (Bozzali et al., 2001) and more recent studies
have found that reductions in the white matter FA in AD patients corre-
late with CSF AD biomarkers of total and phosphorylated tau (Amlien
et al., 2013). The higher ODI and reduced FA in the white matter reﬂectFig. 3. ROI quantiﬁcation of FA, MD (× 10−9 m2/s), ODI, NDI and IsoVF for each animal bthe previously reported disorganisation of the white matter due to ele-
vated tau burden (Sahara et al., 2014). The ability of the NODDI tech-
nique to separate the microstructural compartments that all
contribute to DTI metrics is reﬂected by the higher sensitivity of ODI re-
duced directionality ofwhitematter tissue due to tau pathology (Sahara
et al., 2014) (Supplementary Table 1). Furthermore we examined two
additional regions of the white matter, the ﬁmbria and internal capsule.
In these two regions we found similar changes to that of the corpus
callosum in the TG group with higher ODI, reduced NDI and no signiﬁ-
cant difference in IsoVF in the NODDI technique (Supplementary Fig. 2).
In the cortex, a grey matter region which is normally characterised
by sprawling dendritic processes, the dispersion (i.e. ODI) was reduced
in the TG, and the neurite density (NDI) and isotropic diffusion (IsoVF)
were higher. The increase in ﬁlamentous tau burden (Fig. 2A) and
intraneuronal inclusions has resulted in cortical thinning (Fig. 2B).
Previous ﬁndings have reported a loss of pyramidal cells, a reduction
in cortical volume and an increase in neurite density at this time point
in this TG animal model (Ludvigson et al., 2011). Lower ODI and higherased on distinct anatomical regions. (†= p b 0.05, ††= p b0.01, †††= p b 0.001).
Fig. 4. Correlation of signiﬁcant dMRI measurements with percentage tau burden.
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ity, due to atrophy of the cortical layers and accompanied loss of neurite
structures as previously reported in this animal model (Ludvigson et al.,
2011). As such the tissuewould become less dispersed; leading to lower
ODI and the reduced volume of cortex with higher density is reﬂected
by higher NDI in the TG group. As the cortical structure atrophies the
space becomes occupied by CSF. The higher CSF contamination in-
creases the free diffusion compartment reﬂected by a higher isotropic
volume fraction (IsoVF). The higher MD in this region is likely due to
the partial volume effects of the CSF contamination, and NODDI's ability
to remove the effect of CSF contamination increases the speciﬁcity to
the cytoarchitecture. Interestingly, NDI was the only parameter to cor-
relate with degree of tau pathology, indicating that this parameter
may be sensitive to the underlying nature of the disease process. How-
ever two of the animals may be driving the signiﬁcant differences in the
isotropic volume fraction and neurite density observed in the cortex.
Similarly in the hippocampus, the neurite density was the only param-
eter that correlated with histological measures of tau burden. There are
also region-speciﬁc effects of tau pathology in the marked atrophy of
hippocampus with previously reported neurite loss at 8.5 months
amounting to 85% in dentate gyrus, 82% in CA1 and 69% in CA2/3
(Spires et al., 2006). Currently we do not have the resolution in dMRI
data to separate each compartment of the hippocampus, however the
dramatic loss in neurite projections is reﬂected by the reduced NDI,
and the reduced dispersal of neuron projections is reﬂected by a lower
ODI. The correlations in both the cortex and hippocampus indicate
that NDI may provide higher speciﬁcity to tau pathology formation in
grey matter relative to MD or FA. Correspondingly, in the thalamus,
which has a very low degree of tau burden in comparison to the hippo-
campus and cortex, the FA, MD, ODI and NDI did not discriminate TGfrom WT, although the IsoVF was lower in the TG group. However no
correlation was found between IsoVF and tau burden in the thalamus
(Supplementary Table 1). Previous studies have reported a signiﬁcant
higher MD in the thalamus at 8.5 months in this animal model (Wells
et al., 2015). However due to the lower numbers in this study this
change may not be detected.
DTI has great potential value as a clinical biomarker in AD (Oishi
et al., 2011; Keihaninejad et al., 2013; Ryan et al., 2013). However, al-
though attempts have been made (Molinuevo et al., 2014; Patil and
Ramakrishnan, 2014), it is difﬁcult to relate the parameters directly to
pathological or biological processes. In contrast, a NODDI parameter de-
rived from a biological model of brain cytoarchitecture has displayed a
close correlation with the degree of tau pathology in the TG mouse
model (Supplementary Table 1). This approach could extend the appli-
cability of diffusion imaging in both preclinical models and clinical AD
by providing insight into grey matter microstructural alterations and
their relationship to underlying disease processes, other biomarkers of
AD pathology and clinical or behavioural phenotype.
Limitations
Further work is required to apply this technique to a multi-parame-
ter longitudinal study over the time course of disease. Thiswould deter-
mine the sensitivity of theNODDImetrics to other novel and established
MRmethods in the pre-symptomatic phase of the disease. We envisage
that a multi-parameter longitudinal study would have three separate
animal groups of (1) WT littermates; (2) untreated TG and (3) doxycy-
cline treated TG group (which suppresses tau expression) investigated
from 2 months to 8 months. This study would aim to determine the
speciﬁcity of the NODDI metrics to pathology in the pre-symptomatic
744 N. Colgan et al. / NeuroImage 125 (2016) 739–744phase of the disease and during controlled expression. Although we
have demonstrated speciﬁcity of NODDI metrics in this tau model the
number of mice in this study is low and greater conspicuity may be
reached by increasing the sample size.
Conclusion
The results of this cross-sectional study suggest that NODDI mea-
surements could provide a higher degree of speciﬁcity to the patholog-
ical effects of tau in greymatter, and higher interpretabilitywith respect
to the underlying biological processes, in comparison to traditional DTI
measures.
The NODDI metrics discriminated between the TG and WT groups,
and the correlations between the immunohistological measures of
pathological tau and NODDI measures in the cortex, hippocampus and
corpus callosum demonstrated the heightened speciﬁcity of this tech-
nique in comparison to DTI (Supplementary Table 1). The correlation
of microstructural grey and white matter changes with pathology
represents a new target of investigation in AD which may serve as an
early diagnostic marker of pathology, however in light of the limitations
outlined above, these results must be considered as exploratory at this
point.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neuroimage.2015.10.043.
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